Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis
New England Journal of Medicine, Volume 371, No. 12, Year 2014
Notification
URL copied to clipboard!
Background Tuberculous pericarditis is associated with high morbidity and mortality even if antituberculosis therapy is administered. We evaluated the effects of adjunctive glucocorticoid therapy and Mycobacterium indicus pranii immunotherapy in patients with tuberculous pericarditis.